These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33573698)

  • 21. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
    Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
    Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
    Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming barriers to colorectal cancer screening tests.
    Lachter J; Leska-Aharoni T; Warum D; Eliakim R
    Isr Med Assoc J; 2008; 10(8-9):621-6. PubMed ID: 18847166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.
    Bechtold ML; Ashraf I; Nguyen DL
    South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Korean colonoscopy screening pilot study (K-cospi) for screening colorectal cancer: study protocol for the multicenter, community-based clinical trial.
    Park B; Jun JK; Kim BC; Choi KS; Suh M; ; ; ;
    BMC Gastroenterol; 2021 Jan; 21(1):36. PubMed ID: 33499810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer.
    Bronner K; Mesters I; Weiss-Meilik A; Geva R; Rozner G; Strul H; Inbar M; Halpern Z; Kariv R
    Patient Educ Couns; 2013 Nov; 93(2):272-81. PubMed ID: 23916675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.
    Correia A; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
    Prev Med; 2015 Jul; 76():115-22. PubMed ID: 25895843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
    Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
    Rossi F; Sosa JA; Aslanian HR
    J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.